Recommendations for Standardizing MRI-based Evaluation of Perianal Fistulizing Disease Activity in Pediatric Crohn's Disease Clinical Trials [0.03%]
基于磁共振成像的儿科克罗恩病穿通性肛周瘘管活动评估标准化建议
Eileen Crowley,Christopher Ma,Leonard Guizzetti et al.
Eileen Crowley et al.
Background: Perianal fistulas and abscesses occur commonly as complications of pediatric Crohn's disease (CD). A validated imaging assessment tool for quantification of perianal disease severity and activity is needed to ...
Appendectomy and Risk of Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: A Nationwide Population-based Cohort Study [0.03%]
阑尾切除与炎症性肠病患者结直肠 advanced neoplasia风险的相关性：基于全国人口的队列研究
Anders Mark-Christensen,Eskild Bendix Kristiansen,Pär Myrelid et al.
Anders Mark-Christensen et al.
Background: The aim of this study was to examine the association between appendectomy and advanced colorectal neoplasia (aCRN) in patients with inflammatory bowel disease (IBD). ...
The Future of Therapeutic Drug Monitoring in Inflammatory Bowel Disease: An Emphasis on the Essential Ingredients [0.03%]
炎症性肠病治疗药物监测的未来：强调基本要素
Antonius T Otten,Gerard Dijkstra,Marijn C Visschedijk et al.
Antonius T Otten et al.
Use of Tramadol vs Traditional Opioids and Adverse Outcomes in Patients with Inflammatory Bowel Disease: A Danish Nationwide Cohort Study [0.03%]
一项丹麦全国队列研究：在炎性肠病患者中曲马多的使用与传统阿片类药物相比不利结局：%s
Rahul S Dalal,Ken Lund,Floor D Zegers et al.
Rahul S Dalal et al.
Background: Use of traditional opioids (TOs) for pain management has been associated with adverse outcomes among patients with inflammatory bowel diseases (IBDs). It is unknown if similar associations exist for tramadol, ...
Real-World Effectiveness of Vedolizumab vs Anti-TNF in Biologic-naïve Crohn's Disease Patients: A 2-year Propensity-score-adjusted Analysis from the VEDOIBD-Study [0.03%]
与抗TNF相比， vedolizumab在生物制剂初治的克罗恩病患者中2年的现实有效性：VEDOIBD研究的一项倾向性评分调整分析
Bernd Bokemeyer,Sandra Plachta-Danielzik,Romina di Giuseppe et al.
Bernd Bokemeyer et al.
Background: The aim of this observational, real-world evidence, modified intention-to-treat (mITT) study based on prospectively collected data from the VEDOIBD registry was to compare the effectiveness of vedolizumab (VED...
Observational Study
Inflammatory bowel diseases. 2024 May 2;30(5):746-756. DOI:10.1093/ibd/izad138 2024
Early Biologic Treatment Decreases Risk of Surgery in Crohn's Disease but not in Ulcerative Colitis: Systematic Review and Meta-Analysis [0.03%]
早期进行生物制剂治疗可降低克罗恩病但不能降低溃疡性结肠炎的手术风险：系统评价和.meta.分析
Cindy C Y Law,Bryce Tkachuk,Stephen Lieto et al.
Cindy C Y Law et al.
Background and aims: Inflammatory bowel disease (IBD) can lead to long-term complications that significantly impact patients' quality of life and healthcare resource utilization. Prior studies have demonstrated improved s...
Systematic Review and Meta-Analysis of the Use of Serum Leucine-Rich Alpha-2 Glycoprotein to Assess Crohn's Disease Activity [0.03%]
系统回顾与元分析：血清丰富α2糖蛋白用于评估克罗恩病活动度
Muneyori Okita,Keita Nakashima,Takeshi Yamamura et al.
Muneyori Okita et al.
Background: Although fecal calprotectin is the most widely used biomarker for assessing Crohn's disease activity, serum leucine-rich alpha-2 glycoprotein has recently attracted attention, especially in Japan. Here we perf...
Despite Increased Disease Activity, Women who Attended a Dedicated Inflammatory Bowel Disease and Pregnancy Clinic Had Infants With Higher Apgar Scores: A Population-Based Study [0.03%]
尽管疾病活动性增加，但接受过专门的炎症性肠病和妊娠门诊治疗的妇女所生婴儿的阿氏评分更高：基于人口的队列研究结果
Sangmin Lee,Cynthia H Seow,Kara Nerenberg et al.
Sangmin Lee et al.
Background: Attendance at a subspecialty pregnancy clinic for women with inflammatory bowel disease (IBD) improves disease-specific pregnancy knowledge. We examined the impact of attendance at a dedicated IBD-pregnancy cl...
Clinical and Endoscopic Outcomes After Upadacitinib Induction for Ulcerative Colitis: A Multicenter Retrospective Cohort Study [0.03%]
乌帕替尼诱导治疗溃疡性结肠炎的临床和内镜结局：一项多中心回顾队列研究
Rahul S Dalal,Govind Kallumkal,Heidy J Cabral et al.
Rahul S Dalal et al.
The Evolving Role of Technology in Delivering Patient-centric, Empowered Health Care in Inflammatory Bowel Disease: Patient Experience Using Crohn's Colitis Care e-Health Consumer Platform [0.03%]
技术在患者为中心的炎症性肠病管理中的作用及患者利用Crohn's Colitis Care电子平台的经验体会
Jack McNamara,Susan J Connor,Jane M Andrews
Jack McNamara